3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
NETWORK
2
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Small Cell Lung Carcinoma
3
Multiple Myeloma
2
Hematologic Neoplasms
2
Uterine Cervical Neoplasms
1
Ovarian Neoplasms
1
Lymphoma, Non-Hodgkin
1
Lymphoma
1
Gastro-enteropancreatic neuroendocrine tumor
1
Fallopian Tube Neoplasms
1
Carcinoma
1
Interventions
taxane
2
Surgical Procedures, Operative
2
Poly(ADP-ribose) Polymerase Inhibitors
2
Neoadjuvant Therapy
2
Carboplatin
2
Bevacizumab
2
olaparib
1
niraparib
1
cediranib
1
Platinum
1
Paclitaxel
1
Maintenance
1
Etoposide
1
Drug Therapy
1
Diagnostic Imaging
1
CP protocol
1
Blood Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER_GOV
×
Fallopian Tube Neoplasms
×
Etoposide
×
Clear all
NCT01669226
2016-12-19
AICE
Shanghai Gynecologic Oncology Group
Phase 2
Completed
215 enrolled